| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,118 | 0,124 | 19:46 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.01. | SpineGuard Reports Its Full-year 2025 Revenue | 282 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its digital surgical guidance (DSG) technology, which measures the electrical conductivity of tissues in real... ► Artikel lesen | |
| 05.01. | SpineGuard Announces its 2026 Financial Calendar | 313 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 17.12.25 | PhD Thesis Presentation of Positive Results Obtained by SpineGuard's New Ultrasound Technology | 329 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
| 16.12.25 | SpineGuard: Completion of Capital Increase With Priority Period Maintained for a Gross Amount of €1.2 Million | 282 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its digital surgical guidance (DSG) technology based on local measurement of tissue electrical... ► Artikel lesen | |
| 09.12.25 | SpineGuard announces the launch of a capital increase with cancellation of preferential subscription rights and implementation of a priority period for shareholders for an initial gross amount of €1.6 million secured by commitments amounting to... | 446 | Business Wire | Subscription price: €0.1120 per share, representing a discount of 25.93% on the closing price of the share on December 8th, 2025 Priority period open from December 9th, 2025, to December... ► Artikel lesen | |
| 04.12.25 | SpineGuard Obtains the Clearance of Three New PediGuard Models in China | 332 | Business Wire | Extension to add the Curved and XS PediGuard models
Designation change
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| SPINEGUARD Aktie jetzt für 0€ handeln | |||||
| 24.11.25 | SpineGuard Obtains a U.S. Patent on Its Universal Adapter for Orthopaedic Power Drills and Robots | 288 | Business Wire | Bone breach detection, automatic stop and additional functionalities
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 09.10.25 | SpineGuard Reports Its Q3 2025 Revenue | 403 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 22.09.25 | SpineGuard Obtains European Patent on Automatic Bone Breach Detection by DSG, Applicable to Orthopedic Power Drills and Robots | 361 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
| 10.09.25 | SpineGuard Reports 2025 Half-Year Results and Announces the Implementation of a Bond Financing | 561 | Business Wire | 54% improvement in operating result Implementation of a bond financing for up to €1,000,000
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its... ► Artikel lesen | |
| 16.07.25 | SpineGuard Obtains US Patent on DSG-Enabled Active Safety Stop for Hand-Held Bone Drilling Power Tools in Free-Hand, Navigated or Robotically-Assisted Surgery | 507 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 09.07.25 | SpineGuard Announces Its H1 2025 Revenue | 451 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 29.04.25 | Presentation at CFA Congress of Positive Results Obtained for SpineGuard's New Ultrasound Technology | 544 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
| 15.04.25 | SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales | 638 | Business Wire | Significant reduction in losses of €1.1 million, with consolidated net income improving by 26% in 2024
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
| 09.04.25 | SpineGuard and Omnia Medical Announce the Signature of a Binding Term Sheet for the Transfer of SpineGuard Inc. | 452 | Business Wire | Taking a new strategic step forward in the implementation of the common roadmap established by the two companies announced on January 6, 2025 Integration of PediGuard systems into Omnia... ► Artikel lesen | |
| 14.03.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | 2.002 | Xetra Newsboard | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,210 | -5,06 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius-Aufsichtsrat verlängert Vertrag des Vorstandsvorsitzenden Michael Sen vorzeitig um 5 Jahre --- Christian Pawlu zum 1. Juli für Fresenius Helios in den Vorstand berufen | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Personalie
Fresenius-Aufsichtsrat verlängert Vertrag des Vorstandsvorsitzenden Michael Sen vorzeitig um 5 Jahre --- Christian... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,070 | -3,14 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| THERMO FISHER | 437,55 | +0,61 % | THERMO FISHER SCIENTIFIC INC. - 10-K, Annual Report | ||
| TELADOC HEALTH | 4,395 | -0,34 % | Teladoc Health Q4 Loss Narrows | WASHINGTON (dpa-AFX) - Teladoc Health, Inc. (TDOC) on Wednesday reported a fourth-quarter net loss of $25.1 million, or $0.14 per share, compared to $48.4 million or $0.28 per share last year.Fourth-quarter... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 66,84 | -1,39 % | Eurofins Scientific SE: Weekly Report on Share Repurchases from 23rd February to 27th February 2026 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument ... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| DAVITA | 129,80 | -1,44 % | DaVita Celebrates 20 Years on Fortune's List of World's Most Admired Companies | Two decades of recognition underscore leadership in clinical innovation, employer strategy NORTHAMPTON, MA / ACCESS Newswire / February 26, 2026 / DaVita, a leading provider of comprehensive kidney... ► Artikel lesen | |
| SPINEWAY | 0,147 | -2,26 % | Spineway: 2025 annual results | Ecully, February 17, 2026 - 7:00 p.m. SPINEWAY2025 annual results Revenue up 4%Improved resultsStronger growth potential Condensed consolidated income statement20252024Pro forma* 2024ReportedIn thousands... ► Artikel lesen | |
| DENTSPLY SIRONA | 11,995 | -2,04 % | Dentsply Sirona Q4 Loss Narrows | WASHINGTON (dpa-AFX) - Dentsply Sirona Inc. (XRAY) Thursday reported a fourth-quarter net loss of $146 million or $0.74 per share, compared to $430 million or $2.16 per share last year.Adjusted... ► Artikel lesen | |
| SMITH & NEPHEW | 15,730 | +2,68 % | Ihre wichtigsten Termine: Heute im Fokus: Smith & Nephew, Miele, Bank of Ireland und Raiffeisen Bank | © Foto: Boris Roessler/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 08:00... ► Artikel lesen | |
| SONIC HEALTHCARE | 13,830 | -4,44 % | Laufende Fusionskontrollverfahren: Sonic Healthcare Limited, Sydney /Australien; Erwerb eines Mehrheitsanteils an und alleiniger Kontrolle über die Medizinisches Versorgungszentrum Labor Dr. Klein Dr. Schmitt GmbH, Kaiserslautern | Datum der Anmeldung:31.10.2025Aktenzeichen:B3-103/25Unternehmen:Sonic Healthcare Limited, Sydney/Australien; Erwerb eines Mehrheitsanteils an und alleiniger Kontrolle über die Medizinisches Versorgungszentrum... ► Artikel lesen | |
| DIASORIN | 69,32 | -2,31 % | DiaSorin Launches LIAISON TSH-R Ab Assay In CE Mark Countries | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Friday announced the launch of its new LIAISON TSH-R Ab assay, now available in all countries recognizing the CE Mark.This test is designed to help... ► Artikel lesen | |
| ONTRAK | 0,190 | 0,00 % | NSE - Ontrak, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| FULGENT GENETICS | 12,000 | -1,64 % | Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix | ||
| IMPLANTICA | 4,115 | -0,36 % | Implantica AG: Implantica publishes Year-end Report, January - December 2025 (Q4) | RefluxStop® US Launch Coming Closer, pending FDA approval
Significant events in the fourth quarter
FDA completed six pre-approval inspections during the quarter - including manufacturing sites,... ► Artikel lesen |